Important clinical factors in sequential therapy including lenvatinib against unresectable hepatocellular carcinoma
Atsushi Hiraoka*, Takashi Kumada, Masanori Atsukawa, Masashi Hirooka, Kunihiko Tsuji, Toru Ishikawa, Koichi Takaguchi, Kazuya Kariyama, Ei Itobayashi, Kazuto Tajiri, Noritomo Shimada, Hiroshi Shibata, Hironori Ochi, Toshifumi Tada, Hidenori Toyoda, Kazuhiro Nouso, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Korenobu Hayama
*この論文の責任著者
研究成果: ジャーナルへの寄稿 › 学術論文 › 査読
75
被引用数
(Scopus)